Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.
about
Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapyQuality of life issues in men undergoing androgen deprivation therapy: a reviewPlasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancerCognitive impairment among prostate cancer patients: An overview of reviews.Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study.Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study.Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events.Cardiac and cognitive effects of androgen deprivation therapy: are they real?Combining radiation therapy and androgen deprivation for localized prostate cancer-a critical review.Exercise in clinical cancer care: a call to action and program development description.Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysisThe acute effects of exercise on cortical excitation and psychosocial outcomes in men treated for prostate cancer: a randomized controlled trial.Cardiovascular risk during hormonal treatment in patients with prostate cancer.Management of complications of androgen deprivation therapy in the older man.Biochemical markers of bone turnover and clinical outcomes in men with prostate cancerIs clinical stage T2c prostate cancer an intermediate- or high-risk disease?Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand.The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer.Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study.Proposed mechanisms for cancer- and treatment-related cognitive changesExercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study.Long-term health care costs for prostate cancer patients on androgen deprivation therapy.Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy.Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.Impact of androgen deprivation therapy on cardiovascular disease and diabetes.Radiation therapy and androgen deprivation in the management of high risk prostate cancer.Pharmacotherapeutic management of locally advanced prostate cancer: current status.Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.Do Sex Offenders Have Higher Levels of Testosterone? Results From a Meta-Analysis.Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.Bone health management in men undergoing ADT: examining enablers and barriers to care.Changes in blood glucose and cholesterol levels due to androgen deprivation therapy in men with non-metastatic prostate cancer.Androgen deprivation therapy for prostate cancer: not so simple.Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D.Prostate cancer and osteoporosis.
P2860
Q26864943-87A0FC93-363B-43E0-A96B-259846000D51Q27002887-5BA8EABE-05BD-4EF7-B450-48E182E03606Q27324520-7C4F09CC-DE0F-4667-AC5C-C6DD6A1165E1Q30236039-CF654A48-EE59-4EA7-841F-F441764BAD85Q31127084-6697D903-184A-48A5-8805-14791DE9EA75Q31161608-18E05042-085A-4AC3-BFB7-269549F72E28Q33443421-72ECAE94-8552-4E56-81EB-DEA6A40CC320Q33677118-F8EE0956-08E6-498F-8E37-25016D6E43CEQ33763924-795A4D68-9DA6-41FE-8C26-77CEA42EC369Q34111628-692A50E1-0CD6-4464-AAA4-304EB6A55257Q34171941-06AF2A5D-64D0-45EC-8804-C154BAA39ADAQ34293790-AF6C47BA-C380-439A-B721-ECF9699BDE5AQ34394243-54AC348B-47BA-43E0-BEC8-DF0AC8B1236DQ34574113-EE6BFD61-073D-4C00-AE4C-BFBCDC13FE54Q34721165-2D93D2AF-5E96-4F74-B25D-4ECCD11E8A04Q34782101-2B147DAA-BD5A-45FE-8BE9-6805C058D076Q35022212-CC96FA52-7797-4F2F-981E-306970A0438AQ35536948-1874AE2E-5FDF-4FE1-8EF7-1DCE708C8F6BQ35829609-E7CE50AC-90FB-49B3-BFF5-477A4F8E6380Q35954808-3B359B89-1B83-41D4-90D9-E8277447FEA8Q36133773-19E0AE55-EA9A-46F1-8692-39F7B9252D59Q37279700-ABFDC8FC-A446-4568-AC1E-48AFAEA0DF86Q37342938-0384EF85-2141-49EF-9288-1708C559D991Q37367908-285AF100-EC01-4552-B4BB-D891D60B0721Q37399907-1A04DA0B-8DE4-4692-A903-17042DB9155EQ37583687-11F7DA7B-8D0D-47DF-834A-3CB44273A745Q37583719-72A76858-3F09-49C7-84F9-3A0ECAC66492Q37873973-2AD7083E-2B7A-47E6-9B4D-72353B545AE5Q37888666-C4E7C4BB-28ED-422E-B868-8919DE8A182DQ38156703-4A9D7E2D-195B-444F-9DD1-EBF68F1DE07BQ38434103-CF6D55D3-E150-44DC-94A3-0F3AE3BEDF50Q38783613-8E01F1F7-49EC-45F8-A782-4F11FF449E15Q38830640-39DA85A1-30F1-4BDC-B057-114D3D19FE8FQ41666599-70CBD3FC-5383-4F70-878A-7691C057898EQ41867585-1BAA5864-B1D0-4028-9C20-2841BBFAC749Q41872791-9A7722AC-E48F-4641-9171-97D9415AE64DQ44593887-3F807A99-8522-400F-A6BE-4B0AB60D8585Q45158362-109C0D7F-D07D-4E82-BA59-9F7C93C9CCB1Q45748150-73BDBA0A-4459-4F2B-8E93-592C796EBF39Q45760007-35E08196-A799-4BF5-92E3-6FFA9EF78238
P2860
Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long-term side effects of andr ...... systematic literature review.
@ast
Long-term side effects of andr ...... systematic literature review.
@en
type
label
Long-term side effects of andr ...... systematic literature review.
@ast
Long-term side effects of andr ...... systematic literature review.
@en
prefLabel
Long-term side effects of andr ...... systematic literature review.
@ast
Long-term side effects of andr ...... systematic literature review.
@en
P1476
Long-term side effects of andr ...... a systematic literature review
@en
P2093
Sven Gogov
Zishan Allibhai
P304
P356
10.1016/J.CRITREVONC.2006.06.006
P577
2006-07-24T00:00:00Z